# RWE analysis-data fitness and observability assessment > **Editorial worksheet, not an official FDA, EMA, ENCePP, ISPE, or ISPOR form.** > Complete before cohort construction or outcome modelling. It records the > evidence behind a data-source decision; it does not score, certify, or make a > data source fit for purpose. **Study / program:** [enter] **Decision owner:** [enter] **Version / date:** [enter] **Question and estimand:** [enter target population, treatment strategies, outcome, summary measure, and time horizon] ## 1. Dataset and provenance | Field | Record the evidence, not an assertion | |---|---| | Source and steward | [database, owner, refresh cadence, contact] | | Population and setting | [who can enter, geography, care setting, inclusion mechanism] | | Observation period | [available dates; known changes in capture or coding] | | Analytic extract lineage | [source tables → transformations → analytic dataset; version IDs] | | Linkage, if any | [files linked, method, match rate, unmatched-record handling, linkage validation] | | Access and audit trail | [who can reproduce the extract; log/version locations] | ## 2. Relevance: can the source answer this question? | Required element | Operational definition proposed | Where captured | Coverage / timing evidence | Gap or misclassification risk | Decision and mitigation | |---|---|---|---|---|---| | Target population / eligibility | [enter] | [enter] | [enter] | [enter] | [accept / restrict / augment / stop] | | Treatment / exposure | [enter] | [order, dispense, administration, claim, etc.] | [enter] | [enter] | [enter] | | Comparator | [enter] | [enter] | [enter] | [enter] | [enter] | | Outcome | [enter] | [enter] | [enter] | [enter] | [enter] | | Confounders | [enter] | [enter] | [enter] | [enter] | [enter] | | Follow-up / censoring | [enter] | [enrollment, encounters, death, feed lag] | [enter] | [enter] | [enter] | ## 3. Reliability: can a reviewer trust the captured values? | Dimension | Evidence examined | Finding | Material limitation | Action / owner / due date | |---|---|---|---|---| | Completeness | [missingness, enrollment continuity, feed coverage] | [enter] | [enter] | [enter] | | Conformance | [code-system/version and allowed-value checks] | [enter] | [enter] | [enter] | | Plausibility | [range, chronology, duplicate and impossible-sequence checks] | [enter] | [enter] | [enter] | | Accrual lag | [event-to-availability distribution and cutoff rule] | [enter] | [enter] | [enter] | | Change over time | [coding, benefit, EHR/vendor, or process changes] | [enter] | [enter] | [enter] | | Record linkage | [match rate, error assessment, selection mechanism] | [enter] | [enter] | [enter] | ## 4. Decision record **Fitness conclusion:** [fit as specified / fit with stated restrictions / not fit] **Evidence that would reverse the decision:** [enter] **Required protocol/SAP changes:** [enter] **Approved by / date:** [enter] ## Source basis - U.S. Food and Drug Administration. *Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products*. Guidance for Industry, July 2024. https://www.fda.gov/media/152503/download - Wang SV, Pottegård A, Crown W, et al. HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects. *Pharmacoepidemiology and Drug Safety*. 2023;32:44-55. https://doi.org/10.1002/pds.5507